BioLineRx, Ltd. Company Profile

11:57 EDT 25th June 2018 | BioPortfolio

BioLineRx's ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Founded in 2003 by leaders in the Israeli life-sciences sector, BioLineRx is committed to building a robust pipeline of proprietary therapeutic products.BioLineRx is focused on evaluating, acquiring and advancing projects from lead selection to advanced clinical trials, regulatory approval and marketing. Our emphasis is on professional development in order to maximize the potential of the products we pursue


19 Hartum Street, P.O. Box 45158


Phone: 972-2-548-9100
Fax: 972-2-548-9101

News Articles [11 Associated News Articles listed on BioPortfolio]

BioLineRx: 'Bench to Bedside to Partner' - Bridging the gap between academia and pharma

In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to David Malek, Vice Preident of Business Development of BioLineRx.

Frost & Sullivan Publishes Update Coverage Report on BiolineRx Ltd.: Continued advancement and execution of BiolineRx's lead oncology project - BL-8040; sufficient funds to support clinical strategy; stock target price remains at NIS 5.15

Equity Research is published in the framework of the Tel Aviv Stock Exchange (TASE) Analysis Program TEL AVIV, Israel, March 26, 2018 /PRNewswire/ --TASE analysis project was launched in 2016 in o...

BiolineRx Has Huge Upside In 2018

David Malek, BioLine RX: Building a robust pipeline of promising therapeutics for better health

In this interview filmed at BIO Europe 2013 in Vienna, Paul Larsmon chats to David Malek, Vice President, Business Development at BioLine RX. BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TA...

BioLineRx reports additional Phase IIa data for BL-8040 in AML

BioLineRx's (BLRX) CEO Philip Serlin on Q4 2017 Results - Earnings Call Transcript

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q1 2018 Results - Earnings Call Transcript

BioLineRx reports rosy results from Phase2a trial for its cancer drug BL-8040

When BL-8040 is taken in combination with the chemotherapy drug Cytarabine, the life of patients with relapsed acute myeloid leukemia is extended by several months

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [4 Associated Companies listed on BioPortfolio]

BioLineRx, Ltd.

BioLineRx's ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Founded in 2003 by leaders in the Israeli life-sciences secto...

BioLineRx Ltd.

BioLineRx Ltd. is a publicly traded (TASE:BLRX) biopharmaceutical development company based in Jerusalem, Israel. BioLineRx is dedicated to identifying, in-licensing and developin...

BioLineRx Ltd. and Compugen Ltd.

BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...

Yissum Research Development Company Ltd. and BioLineRx Ltd.

More Information about "BioLineRx, Ltd." on BioPortfolio

We have published hundreds of BioLineRx, Ltd. news stories on BioPortfolio along with dozens of BioLineRx, Ltd. Clinical Trials and PubMed Articles about BioLineRx, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLineRx, Ltd. Companies in our database. You can also find out about relevant BioLineRx, Ltd. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record